Association of visceral fat and plasmacytoid dendritic cell-derived interferon alpha with SARS-CoV-2 infection
Type I interferon (IFN-I: IFNα/β) production by plasmacytoid dendritic cells (pDCs) is critical for controlling viral infections. Visceral fat obesity is associated with severe outcomes in viral infections, but its effect on pDC-mediated IFN-I production in the context of SARS-CoV-2 infection remains unclear. This cross-sectional study evaluated cytokine production by blood pDCs in response to TLR7/8 stimulation and analyzed its association with visceral fat area (VFA). IFN-I production was exclusively observed in pDCs following TLR7/8 stimulation. The proportion of IFNα-positive pDCs (pDC-IFNα) was significantly lower in individuals with high VFA (above the median) and negatively correlated with VFA (r = -0.27, P < 0.001). Logistic regression revealed that high VFA or low pDC-IFNα levels (below the median) were independently associated with a history of SARS-CoV-2 infection. Moreover, individuals with both high VFA and low pDC-IFNα levels had significantly higher odds of infection compared to those with low VFA and high pDC-IFNα levels. These findings suggest a potential relationship between VFA and impaired pDC function, which may influence susceptibility to SARS-CoV-2 infection. Managing VFA and enhancing pDC responses might represent strategies to reduce infection risk in individuals with visceral fat obesity.
Authors
- Ryohei Tsuji (ORCID: https://orcid.org/0000-0002-8547-6846)
- Daisuke Fujiwara (ORCID: https://orcid.org/0000-0002-6230-5534)
- Hideto Takase (ORCID: https://orcid.org/0000-0003-1185-7141)
- Noriko Osaki
- Mikio Arita
- Nobuyuki Miyai (ORCID: https://orcid.org/0000-0002-7208-4405)
- Naoki Ozato (ORCID: https://orcid.org/0000-0002-2038-4705)
- Shota Hori
Institutions
- Wakayama Medical University (JP)
- Kao Corporation (Japan) (JP)
- Kirin (Japan) (JP)
Publication Details
- Journal
- PLoS ONE
- Published
- 2026-04-10
- DOI
- https://doi.org/10.1371/journal.pone.0344870
- Primary Topic
- COVID-19 Clinical Research Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Japan Society for the Promotion of Science London
- Kao Corporation
- Japan Society for the Promotion of Science